Clinical Trial

Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after stroke. This study aims to utilize machine learning technology to integrate multi-dimensional indicators of patients with ischemic stroke, establish a risk prediction model for PSD, and assist in early, accurate, and individualized assessment of PSD risk in clinical practice.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-08; most recent amendment 2026-02-03.
Status change: Not Yet Recruiting → Recruiting 2026-02-03
Trial Details
NCT Number NCT07294274
Lead Sponsor Min Su
Collaborators: Chongqing Traditional Chinese Medicine Hospital
Conditions Post-stroke Depression
Enrollment 488 participants
Start Date 2025-11-01
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-05